Penumbra (PEN) said Monday it received the CE Mark in Europe for its computer-assisted vacuum thrombectomy technologies Lightning Flash 2.0 and Lightning Bolt 7.
The technologies are used to remove clots in the vascular system, the company said.
Penumbra said the products will assure doctors in Europe that computer-assisted vacuum thrombectomy is a reliable initial choice for treating diseases including pulmonary embolism, venous thrombosis, and sudden limb ischemia.
Shares of Penumbra rose 1% in recent trading.
Price: 188.89, Change: +1.95, Percent Change: +1.04
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments